De-Escalating Bone-Modifying Therapy Safe, Effective in Metastatic Breast Cancer

(MedPage Today) — BERLIN — Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for patients with bone metastases from breast cancer, and also appeared to be safe in prostate cancer…